Imunon (IMNN) Live Share Price, Invest From India

Imunon Stock Performance

as on September 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.33
Day's Price Range
$1.42
$1.36
2.21%
Downside
4.41%
Upside
52 Week's Low
52 Week's High
$1.35
52-Week Price Range
$5.64
$1.36
0.74%
Downside
315.04%
Upside

Imunon share price movements today

Previous Close: $1.38
Open: $1.41
Volume: 355.6K
Market Cap: $7.7M
Day's Low - High: $1.33 - $1.42
52 Week Low - High: $1.35 - $5.64

Imunon Historical Returns

1 Month Return: -12.66 %
3 Month Return: -24.18 %
1 Year Return: -72.29 %
3 Year Return: -90.55 %
5 Year Return: 0 %

Imunon Stock Fundamentals & Key Indicators

Check Imunon market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.7M

EPS (TTM)

-4.53

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.3

Industry PE ratio

-2.37

PEG Ratio

-0.002280214992183681

EBITDA

-14.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-314.89%

Imunon Stock Valuation

Track how Imunon P/E has moved over time to understand its valuation trends.

Imunon in the last 5 years

Overview
Trends

Lowest (-0.68x)

December 31, 2024

Industry (-2.37x)

March 31, 2026

Today (-0.56x)

March 31, 2026

Highest (-0.16x)

March 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -0.56x

Imunon vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Imunon with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Imunon	BUY	$7.7M	NA	-0.3	0.00%	0.00%
Moderna	BUY	$63.1B	-63.24%	-19.81	-12.57%	0.00%
Vertex Pharmaceuticals	BUY	$130.1B	174.21%	29.81	86.04%	0.00%
Regeneron	BUY	$79.7B	21.1%	18.48	84.86%	0.48%

Stock Returns calculator for Imunon Stock including INR - Dollar returns

The Imunon stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Imunon investment value today

Current value as on today

₹29,721

Returns

-₹70,279

(-70.28%)

Returns from Imunon Stock

-₹72,691 (-72.69%)

Dollar Impact

₹2,412 (+2.41%)

Analyst Recommendation on Imunon Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Imunon. Average target price of $17

Imunon Share Price Target

Get share price movements and forecasts by analysts on Imunon.

What analysts predicted

92%UPSIDE

Target Price

$17

Current Price

$1.36

Analyzed by

2 Analysts

Target

$17.00

Imunon target price $17, a slight upside of 92% compared to current price of $1.36. According to 2 analysts rating.

Indian Investors' Interest in Imunon Stock

Search interest for Imunon Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 21, 2026 to September 20, 2026

Change:-20% versus previous 30 day period

Imunon Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-3	0	-2	0	-	0	-
Operating Income	-5	-5	-5	-4	-4	-4	-2	-3	-4	-2
EBITDA	-6	-4	-4	-4	-3	-4	-2	-3	-4	-2
Interest Expense	0	-	-	-	-	-	-	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-4	-4	-4	-4	-4	-2	-3	-4	-2
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-4	-4	-4	-4	-4	-2	-3	-4	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Imunon Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Mar 2022	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Total Revenue	0	0	0	0	0	0	-	-	-
Gross Profit	0	0	0	0	0	0	-	-	-
Operating Income	-18	-21	-20	-18	-21	-24	-21	-19	-14
EBITDA	-19	-21	-16	-21	-20	-31	-19	-17	-13
Interest Expense	0	0	1	1	0	5	0	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-20	-22	-18	-23	-22	-37	-20	-18	-14
Income Tax Expense	-	-10	-1	-1	-1	-1	-1	-	-
Net Income	-20	-11	-16	-21	-20	-35	-19	-18	-14
Net Profit Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	0.00%	0.00%	0.00%

Imunon Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Net Income	-4	-4	-4	-4	-4	-4	-2	-3	-4	-2,814
Operating Cash Flow	-3	-5	-4	-4	-4	-2	-2	-4	-3	-3,990
Investing Cash Flow	-3	2	7	0	0	0	0	-	-	-69
Financing Cash Flow	0	-	-	9	0	0	4	4	0	11,007
Change in Cash	-7	-3	2	5	-4	-3	1	0	-3	6,947

Imunon Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Mar 2022	Dec 2022	Dec 2023	Dec 2024	Mar 2026
Net Income	-20	-11	-16	-21	-20	-35	-19	-18	-14
Operating Cash Flow	-16	-7	-20	-15	-16	-23	-19	-18	-13
Investing Cash Flow	-10	-1	5	7	-30	8	11	9	0
Financing Cash Flow	36	10	7	17	54	6	-3	9	17
Change in Cash	8	1	-6	10	8	-8	-11	0	2

Mutual Funds that own Imunon Stock

Check out the Mutual Funds with significant holdings in Imunon.

Funds	Holdings	Shares Held
Fidelity Concord Street Trust	0.396086%	22226
VANGUARD INDEX FUNDS	0.30716%	17236

Global Institutional Holdings in Imunon

Funds	Holdings
Vanguard	0.84%

Insights on Imunon

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -4.24M → -2.81M (in $), with an average increase of 51.0% per quarter
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 44.3% return, outperforming this stock by 135.0%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 583.0%
NEGATIVE IMPACT
Price Dip
In the last 6 months, IMNN stock has moved down by -53.9%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 7.05M → -725.20K (in $), with an average decrease of 144.7% per quarter

About Imunon

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently in development for various cancer indications. Additionally, Imunon possesses two feasibility-stage platform technologies aimed at creating nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Established in 1982 and based in Lawrenceville, New Jersey, the firm was known as Celsion Corporation before rebranding to Imunon, Inc. in September 2022.

Organisation	Imunon
Headquarters	997 Lenox Drive, Lawrenceville, NJ, 08648, US
Industry	Biotechnology
CEO	Stacy R. Lindborg
E-voting on shares	Click here to vote

Key Management of Imunon

Name	Title
Ms. Kristin Longobardi M.B.A.	Senior Vice President of Strategic Operations
Mr. Michael H. Tardugno	Executive Chairman
Dr. Stacy R. Lindborg Ph.D.	President, CEO & Director
Dr. Douglas V. Faller M.D., Ph.D.	Chief Medical Officer
Mr. Joshua Blacher CPA, M.B.A.	Interim CFO, Principal Financial Officer & Principal Accounting Officer
Ms. Susan Mary Eylward	General Counsel & Corporate Secretary

FAQs

What is Imunon share price today?

Imunon share price today is $1.36 as on September 19, 2026 at 8:45 am IST at the close of the market. Imunon share today touched a day high of $1.42 and a low of $1.33.

What is the 52 week high and 52 week low for Imunon share?

Imunon share touched a 52 week high of $5.64 on January 1, 1970 and a 52 week low of $1.35 on January 1, 1970. Imunon stock price today i.e. September 19, 2026 at 8:45 am IST is closed at $1.36,which is 75.91% down from its 52 week high and 0.74% up from its 52 week low.

What is Imunon's market capitalisation today?

Imunon market capitalisation is $0.00T as on September 19, 2026 at 8:45 am IST.

How to invest in Imunon Stock (IMNN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Imunon on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Imunon Shares that will get you 1.1029 shares as per Imunon share price of $1.36 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Imunon Stock (IMNN) from India?

Indian investors can start investing in Imunon (IMNN) shares with as little as ₹95.88 or $1 (as of September 20, 2026 at 12:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Imunon stock (as per the Rupee-Dollar exchange rate as on September 20, 2026 at 12:41 am IST). Based on Imunon share’s latest price of $1.36 as on September 19, 2026 at 8:45 am IST, you will get 7.3529 shares of Imunon. Learn more about fractional shares .